Why Doctors Are Rethinking How They Assess Weight in Aging HIV Patients

Modern antiretroviral therapy has turned HIV into a manageable, long-term condition for millions of people, which means more people with HIV are now aging into their 60s, 70s, and beyond. A new review argues that the medical field’s usual way of tracking their health, body weight, is quietly missing an important part of the picture.^[1]

The researchers, writing in Current Opinion in HIV and AIDS, note that weight gain in people with HIV during the current treatment era often reflects a specific pattern: increased visceral fat (the metabolically active fat around organs) and ectopic fat (fat stored in places like muscle and liver where it doesn’t belong) rather than simple, uniform weight gain. The result can be someone who looks like they’ve gained healthy weight on a scale while actually losing functional muscle underneath, a combination the review calls sarcopenic obesity.

Muscle quality, not just muscle quantity

The review highlights a related concept called myosteatosis, fat infiltrating directly into muscle tissue, as a likely mechanistic link between rising adiposity and declining physical function in aging people with HIV. In practice, that means two people with HIV who weigh the same and have similar muscle size on paper can have very different real-world strength and frailty risk, depending on how much fat has crept into that muscle.

On the encouraging side, the review points to exercise interventions, especially resistance training, as showing real promise for preserving physical function, reducing frailty, and improving body composition in this population. It flags a more cautious note about pharmacologic weight-loss treatment: without a concurrent focus on preserving muscle, drug-driven weight loss risks removing lean tissue along with fat, which could make the underlying sarcopenic obesity problem worse rather than better. The bottom line for aging people with HIV, and really their care teams, is that “how much do you weigh” is an incomplete question; “how is your muscle holding up” deserves equal attention.

References

• Oliveira VHF, Brown TT, Erlandson KM. “Reframing obesity in aging people with HIV: sarcopenic obesity, muscle quality, and frailty.” Current Opinion in HIV and AIDS, 2026. DOI: 10.1097/COH.0000000000001067. Finding used: the review argues that weight gain in aging people with HIV in the modern antiretroviral era often reflects increased visceral and ectopic adiposity rather than uniform weight gain, identifies sarcopenic obesity and myosteatosis (fat infiltration into muscle) as key mechanistic links to functional decline, and highlights resistance-based exercise as promising for preserving function while cautioning that pharmacologic weight loss without a muscle-preservation focus may harm lean tissue. ↑︎

Kurt Greiner

Kurt is a digital strategist and IT professional blending emerging technology with practical application to help businesses and individuals streamline their digital presence. His current work focuses on the intersection of intentional living and technological resilience, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.